CN1A autoantibodies have previously been reported to be highly specific for sporadic IBM, which is a progressive degenerative muscle disease of autoimmune origin, suggesting that they play a pathogenic role by interfering with protein degradation [26]. The gene discussed is NT5C1A; the disease is inclusion body myositis.